SCHEMBL18964246

SCHEMBL18964246

CCN(C)[S+]([O-])c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCCNC4=O)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ KCNH2 Q12809 2/20 0.36
▸ CDK4 P11802 2/20 0.35
▸ CCND1 P24385 2/20 0.35
▸ CCND3 P30281 2/20 0.35
▸ CDK6 Q00534 2/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ MNAT1 P51948 1/20 0.34
▸ ATR Q13535 9/20 0.34
▸ PTK2 Q05397 1/20 0.34
▸ PTK2B Q14289 1/20 0.34
▸ PRKDC P78527 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ PARP10 Q53GL7 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12077162 0.84 KCNH2 (0.41) MAPK1GSK3BKCNH2CDK2ATR
SCHEMBL18964018 0.81 MAPK1 (0.39) MAPK1GSK3BCDK4CCND1CCND3
SCHEMBL12495193 0.80 MAPK1 (0.41) MAPK1GSK3BKCNH2ATRPTK2
SCHEMBL12496279 0.78 MAPK1 (0.42) MAPK1GSK3BKCNH2CDK4CCND1
SCHEMBL27157654 0.76 CHEK1 (0.57) MAPK1GSK3BKCNH2CDK4CCND1
SCHEMBL12495504 0.75 MAPK1 (0.41) MAPK1GSK3BKCNH2CDK4CCND1
SCHEMBL12495170 0.75 MAPK1 (0.45) MAPK1GSK3BKCNH2ATRPRKDC
SCHEMBL12495622 0.74 MAPK1 (0.43) MAPK1GSK3BKCNH2CDK4CCND1
SCHEMBL12077869 0.74 MAPK1 (0.46) MAPK1GSK3BKCNH2CDK4CCND1
SCHEMBL12495736 0.74 CDK4 (0.46) MAPK1GSK3BKCNH2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681206-B1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS INC (US) 2017-06-14 — — EP disclosed
Send feedback